Reply: Aberrant splicing induced by the most common EPG5 mutation in an individual with Vici syndrome.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

1. The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy.Autophagy · 2022
   Article
2. Insights on autophagosome-lysosome tethering from structural and biochemical characterization of human autophagy factor EPG5.Communications biology · 2021
   Article
3. The Vici syndrome protein EPG5 regulates intracellular nucleic acid trafficking linking autophagy to innate and adaptive immunity.Autophagy · 2018
   Article

Corrections and comments

• Comment on
  EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.2016
• Comment on
  Aberrant splicing induced by the most common EPG5 mutation in an individual with Vici syndrome.2016

Authors and funding

5 authors at 5 institutions in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as